Hypercalcemia Of Malignancy

Hypercalcemia of Malignancy is a pathological condition characterized by elevated serum calcium levels resulting from tumor-induced mechanisms, most commonly mediated by osteolytic bone metastases or humoral factors such as parathyroid hormone-related protein.

1K

Publications

49.3K

Citations

3.7K

Authors

913

Institutions

Publications per year

2017–2026

41

Authors

3.7K

  1. AF
    Andrew F. Stewart

    Yale University, United States

    31 publications · 3.3K citations

    28

    h-index

  2. GR
    Gregory R. Mundy

    The University of Texas at San Antonio Health Science Center, United States

    25 publications · 1.8K citations

    22

    h-index

  3. KI
    Karl Insogna

    Yale University, United States

    22 publications · 2.1K citations

    19

    h-index

  4. TJ
    Thomas J. Rosol

    The Ohio State University, United States

    23 publications · 989 citations

    18

    h-index

  5. WJ
    William J. Burtis

    Yale University, United States

    18 publications · 1.7K citations

    16

    h-index

1–5 of 3.7K

Venues

  1. PubMed

    Repository · 128 publications · 4.5K citations

    36

    h-index

  2. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 65 publications · 4K citations

    36

    h-index

  3. Cancer

    61 publications · 2.9K citations

    32

    h-index

  4. Endocrinology

    36 publications · 1.6K citations

    24

    h-index

  5. Journal of Bone and Mineral Research

    JBMR · 28 publications · 1.4K citations

    22

    h-index

1–5